Medical Drugs News
-
Showcase
Empatica and BARDA Join Forces to Validate Wearable System That Detects COVID-19 Before Symptoms Appear
BOSTON, June 19, 2020 /PRNewswire/ -- Digital healthcare company Empatica announces a pioneering new partnership with the Biomedical Advanced Research and Development Authority ("BARDA"), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services (HHS), to validate an early warning system for COVID-19 and other respiratory ...
-
Showcase
ALung Announces Commercial Development of its Breakthrough Next Generation Artificial Lung
PITTSBURGH–(BUSINESS WIRE)– April 4, 2020 – ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, announced the recent initiation of commercial development of its next generation artificial lung, which expands the Company’s focus on highly efficient gas ...
-
Creative Enzymes Announces the Launch of Kex2 Protease from Saccharomyces Cerevisiae, Recombinant
Creative Enzymes, a professional enzyme provider located in New York, USA, is always hammering away at research and trials in order to provide customers with enzyme services and products using its greatest effort. Creative Enzymes recently announced the launch of Kex2 Protease from Saccharomyces cerevisiae, Recombinant, for the cleavage of secreted peptides in yeast exogenous protein expression. ...
-
Creative Proteomics Cytokine Accelerates Your Project with Its Colony Stimulating Factor Detection Service
The Cytokine division belongs to Creative Proteomics, which specializes in providing cytokine research and analysis services for researchers in the pharmaceutical and biotechnology industries, as well as academic institutes and government agencies. Creative Proteomics Cytokine recently announced the launch of the colony stimulating factor detection platform for scientific research. ...
-
Creative Proteomics Has Optimized Pre-treatments and Assays for Different Types of Vitamins
Metabolomics, a subdivision of Creative Proteomics, is dedicated to providing metabolomics services based on cutting-edge LC-MS technology for biomedical research institutions, biotechnology companies, and pharmaceutical companies. Creative Proteomics has developed highly sensitive, selective and accurate LC/MS/MS analytical solutions for the identification and quantification of vitamins in ...
-
Pronalyse Unveils Insightful Metabolite Identification Services of Biopharmaceuticals
Pronalyse is a new division of Creative Proteomics, which is an integrated CRO company with rich experience in providing drug development services. Building on its years of experience, Creative Proteomics Pronalyse announces the launch of its metabolite identification services of biopharmaceuticals for an accurate and efficient analysis of the metabolism for your biological drugs in vivo. The ...
-
CO2 laser treatment for acne scars
The scars left by acne are directly related to blood heat and dampness toxin. The accumulation of blood toxins in the body, the decline in the blood’s ability to carry and supply oxygen, and the poor blood microcirculation make skin cells unable to obtain the oxygen and nutrients required for normal metabolism and damage. Due to the normal metabolic environment of skin cells, and the ...
-
VBI Vaccines Secures $100 Million Debt Facility From K2 HealthVentures
VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced it has entered into a refinanced and upsized debt facility of up to $100 million with its existing lender, K2 HealthVentures (K2HV), a healthcare-focused specialty finance company. Under the terms of the agreement, $50 million is ...
-
BOC Sciences 2022 Free Webinar: Viral RNA Modifications and Implications for Novel Therapeutics
BOC Sciences grandly announced the schedule of a free webinar on September 19th, 2022, at 11:00 EDT, which is a laudable event centering on the hot spot of RNA research during the pandemic. BOC Sciences is an expert in RNA technologies. It is now renowned as the largest manufacturer of pseudoUridine and its derivatives, the critical materials for RNA modification. BOC Sciences' annual ...
By BOC Sciences
-
BOC Sciences August Promotion: Compound Docking Solutions for Drug Discovery
As the leading expert in computer-aided drug discovery, BOC Sciences has developed compound docking technologies to facilitate the discovery of novel ligands for over 30 targets. Has compound docking ever brought us medicine? This was generally questioned in the pharmaceutical industry. With many innovators like BOC Sciences springing up and improvements being made in computational chemistry, ...
By BOC Sciences
-
New ARASENS data reinforce strong tolerability profile of darolutamide plus ADT and docetaxel without compromising quality of life for patients with mHSPC
New results from the Phase III ARASENS trial evaluating quality of life (QoL) and patient-relevant endpoints for darolutamide plus androgen deprivation therapy (ADT) and docetaxel in patients with metastatic hormone-sensitive prostate cancer (mHSPC) show that, in addition to extending overall survival (OS), darolutamide has a strong tolerability profile and ability to maintain patient QoL with ...
By Bayer AG
-
Valneva and VBI Vaccines Announce European Partnership for Marketing and Distribution of PreHevbri
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) (Valneva) and VBI Vaccines Inc. (Nasdaq: VBIV) (VBI) today announced a partnership in select European markets for the marketing and distribution of PreHevbri® [Hepatitis B vaccine (recombinant, adsorbed)], the only 3-antigen hepatitis B vaccine approved in Europe. Under the terms of the agreement, specialty vaccine company Valneva will promote ...
-
CanaQuest Launches Mentanine (R) (Cannabidiol + IP Formula) in the US via www.canaqueststore.com, Supported by Western University Pre-Clinical Trials Targeting Anxiety, Depression and PTSD
Canaquest Medical Corp (OTC Pink:CANQF) (the "Company" or "CanaQuest"), an award-winning, Clinical Stage/Life-Sciences company focused on drug discovery and development of next-generation targeted therapeutics within the endocannabinoid system and specific brain receptors, today announced its US launch of all-natural Mentanine® (cannabidiol "CBD" + IP, Omega-3s, DHA, EPA formula) in ...
-
Canaquest Launches Mentanine (Cannabidiol + IP Formula) in the US via www.canaqueststore.com, Supported by Western University Pre-Clinical Trials Targeting Anxiety, Depression and PTSD
Canaquest Medical Corp (OTC PINK:CANQF) (the “Company” or “CanaQuest“), an award-winning, Clinical Stage/Life-Sciences company focused on drug discovery and development of next-generation targeted therapeutics within the endocannabinoid system and specific brain receptors, today announced its US launch of all-natural Mentanine (cannabidiol “CBD” + IP, Omega-3s, ...
-
ATsens signed Domestic Distribution Agreement with Hanmi Pharmaceutical Co., Ltd.
AT-Patch is distributed to domestic clinics through Hanmi Pharmaceutical Co., Ltd. Expect to expand ATsens' product line with this Strategic MOU ...
-
BOC Sciences Yields Peptide-siRNA Conjugates of High Quality
BOC Sciences offers synthesis and conjugation of siRNA to the targeted peptide with high quality and yield, hoping to help researchers achieve substantial preclinical progress for RNAi therapeutics. The peptide-siRNA conjugation technology uses peptide as a carrier for nucleic acids to bring short siRNA into the body, thus exerting the gene silencing effect of siRNA specifically toward target ...
By BOC Sciences
-
Cell Apoptosis Kits at Creative Biogene: Efficient and Convenient
Creative Biogene unveiled a rich portfolio of efficient cell apoptosis assay kits targeted to detect mitochondrial permeability transition pore (MPTP) as well as mitochondrial membrane potential (MMP) to assist researchers in mitochondrial studies. Mitochondrial dysfunction has been linked to a variety of market therapeutics and pathological diseases. Therefore, studying or maintaining ...
-
Creative Peptides Released One-Stop Solution for All Peptide Drug Conjugate Needs
Peptide drug conjugate (PDC) is emerging as a novel type of conjugate drug, showing advantageous features over antibody-drug conjugates (ADCs). As a dedicated peptide manufacturer, Creative Peptides provides a one-stop solution for all peptide drug bioconjugation needs to help pharmaceutical clients bring more PDCs to the market. Structurally, PDC mainly contains three elements—cytotoxin, ...
-
Accelerated Shelf-Life Testing to Assess Drug Stability
In recent decades, shelf-life prediction is increasingly recognized as an important and necessary part of any new product development. Fully aware of this, CD Formulation, a New York-based CRO company reputed for high-quality drug pre-formulation services, announced earlier this month to have launched long-term accelerated shelf-life testing for drug developers and pharmaceutical companies ...
-
Alfa Chemistry: Hydrophilic Polymers Exhibit Boundless Opportunities for Multiple Fields
Synthetic polymer chemistry opens up novel opportunities for water-soluble polymers. Among them, hydrophilic polymers have been most extensively studied. Earlier this month, Alfa Chemistry released a broad portfolio of hydrophilic polymers, aiming to facilitate relevant polymer research that has prominent applications for drug delivery, gene delivery, and protein delivery to self-assembly, ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you